122 related articles for article (PubMed ID: 37715313)
21. Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival.
Geissler K; Jäger E; Barna A; Graf T; Graf E; Öhler L; Hoermann G; Valent P
Eur J Haematol; 2021 May; 106(5):627-633. PubMed ID: 33432601
[TBL] [Abstract][Full Text] [Related]
22. Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Elbæk MV; Sørensen AL; Hasselbalch HC
Leuk Lymphoma; 2016 Aug; 57(8):1793-9. PubMed ID: 26879691
[TBL] [Abstract][Full Text] [Related]
23. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.
Gadgeel SM; Severson RK; Kau Y; Graff J; Weiss LK; Kalemkerian GP
Chest; 2001 Jul; 120(1):55-63. PubMed ID: 11451816
[TBL] [Abstract][Full Text] [Related]
24. Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
Machherndl-Spandl S; Jäger E; Barna A; Gurbisz M; Marschon R; Graf T; Graf E; Geissler C; Hoermann G; Nösslinger T; Pfeilstöcker M; Bettelheim P; Zach O; Weltermann A; Heibl S; Thaler J; Zebisch A; Sill H; Stauder R; Webersinke G; Kusec R; Ulsperger E; Schneeweiss B; Öhler L; Germing U; Valent P; Tüchler H; Geissler K
Eur J Haematol; 2021 Aug; 107(2):265-274. PubMed ID: 33998054
[TBL] [Abstract][Full Text] [Related]
25. Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
Harel S; Cherait A; Berthon C; Willekens C; Park S; Rigal M; Brechignac S; Thépot S; Quesnel B; Gardin C; Adès L; Fenaux P; Braun T
Leuk Res; 2015 May; 39(5):501-4. PubMed ID: 25735917
[TBL] [Abstract][Full Text] [Related]
26. Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia.
Helbig G; Chromik K; Woźniczka K; Kopińska AJ; Boral K; Dworaczek M; Koclęga A; Armatys A; Panz-Klapuch M; Markiewicz M
Pathol Oncol Res; 2019 Jul; 25(3):1175-1180. PubMed ID: 30613922
[TBL] [Abstract][Full Text] [Related]
27. [Clinical Characteristics and Survival Analysis of Patients with Chronic Myelomonocytic Leukemia].
Wang JY; Chen JF; Wang SF; Guo QH; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):476-482. PubMed ID: 37096522
[TBL] [Abstract][Full Text] [Related]
28. Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study.
Moreno Berggren D; Kjellander M; Backlund E; Engvall M; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ungerstedt J; Ejerblad E
Br J Haematol; 2021 Feb; 192(3):474-483. PubMed ID: 32501529
[TBL] [Abstract][Full Text] [Related]
29. Models of Prognostication in Chronic Myelomonocytic Leukemia.
Onida F
Curr Hematol Malig Rep; 2017 Dec; 12(6):513-521. PubMed ID: 29064026
[TBL] [Abstract][Full Text] [Related]
30. Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.
Kim HY; Lee KO; Park S; Jang JH; Jung CW; Kim SH; Kim HJ
Ann Lab Med; 2018 Nov; 38(6):495-502. PubMed ID: 30027691
[TBL] [Abstract][Full Text] [Related]
31. Asthma and risk of myelodysplastic syndromes: a population-based cohort study.
Frederiksen H; Farkas DK; Horváth-Puhó E; Nørgaard JM; Nørgaard M; Sørensen HT
Br J Cancer; 2017 Jan; 116(1):100-102. PubMed ID: 27898660
[TBL] [Abstract][Full Text] [Related]
32. Effect of Gender, Energetics, and Biomechanics on Swimming Masters Performance.
Ferreira MI; Barbosa TM; Neiva HP; Marta CC; Costa MJ; Marinho DA
J Strength Cond Res; 2015 Jul; 29(7):1948-55. PubMed ID: 25635608
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution.
Tang G; Zhang L; Fu B; Hu J; Lu X; Hu S; Patel A; Goswami M; Khoury JD; Garcia-Manero G; Medeiros LJ; Wang SA
Am J Hematol; 2014 Aug; 89(8):813-8. PubMed ID: 24782398
[TBL] [Abstract][Full Text] [Related]
34. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
[TBL] [Abstract][Full Text] [Related]
35. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
36. A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller S; Stauder R; Kuehr T; Lang A; Machherndl-Spandl S; Mayrbaeurl B; Noesslinger T; Petzer A; Valent P; Greil R; Thaler J
Leuk Lymphoma; 2018 May; 59(5):1121-1126. PubMed ID: 28853315
[TBL] [Abstract][Full Text] [Related]
37. Investigating short- and long-term transfer effects of a Taiji beginner course in participants' daily life.
Schitter AM; Ausfeld-Hafter B; Nedeljkovic M
J Integr Med; 2013 Sep; 11(5):295-304. PubMed ID: 24063776
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.
Wedge E; Hansen JW; Dybedal I; Creignou M; Ejerblad E; Lorenz F; Werlenius O; Ungerstedt J; Holm MS; Nilsson L; Kittang AO; Antunovic P; Rohon P; Andersen MK; Papaemmanuil E; Bernard E; Jädersten M; Hellström-Lindberg E; Grønbæk K; Ljungman P; Friis LS
Transplant Cell Ther; 2021 Dec; 27(12):991.e1-991.e9. PubMed ID: 34500124
[TBL] [Abstract][Full Text] [Related]
39. Immune thrombocytopenia in chronic myelomonocytic leukemia.
Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
Onida F; Kantarjian HM; Smith TL; Ball G; Keating MJ; Estey EH; Glassman AB; Albitar M; Kwari MI; Beran M
Blood; 2002 Feb; 99(3):840-9. PubMed ID: 11806985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]